个人科研网厅 | | 帮助
首都医科大学宣武医院知识库
高级检索
当前位置： 首页 > 详情页

Regorafenib plus PD-1 inhibitors in Chinese patients with microsatellite stable/mismatch repair proficient metastatic colorectal cancer: A real-world study

| 导出 | |

文献详情

资源类型：
WOS体系：

收录情况： ◇ SCIE ◇ CPCI(ISTP)

作者：
Yang, Kaili[1,2,3,4,5,6,7,8,9,10] * ; Han, Lu[1,2,3,4,5,6,7,8,9,10] ; Zhao, Yun-Bo[1,2,3,4,5,6,7,8,9,10] ; Ge, Yang[1,2,3,4,5,6,7,8,9,10] ; Li, Qin[1,2,3,4,5,6,7,8,9,10] ; Wang, Yusheng[1,2,3,4,5,6,7,8,9,10] ; Wu, Shikai[1,2,3,4,5,6,7,8,9,10] ; Zhang, Yan[1,2,3,4,5,6,7,8,9,10] ; Zhao, Chuanhua[1,2,3,4,5,6,7,8,9,10] ; Zhou, Jing[1,2,3,4,5,6,7,8,9,10] ; Zhao, Lin[1,2,3,4,5,6,7,8,9,10] ;
机构： [1]Peking Union Med Coll Hosp, Beijing, Peoples R China [2]Chinese PLA Gen Hosp, Dept Med Oncol, Beijing, Peoples R China [3]Beijing Hosp, Beijing, Peoples R China [4]Capital Med Univ, Beijing Chaoyang Hosp, Beijing, Peoples R China [5]Capital Med Univ, Beijing Friendship Hosp, Beijing, Peoples R China [6]Shanxi Med Univ, Affiliated Canc Hosp, Shanxi Canc Hosp, Taiyuan, Peoples R China [7]Hosp Acad Mil Med Sci, Beijing, Peoples R China [8]Capital Med Univ, Xuanwu Hosp, Beijing, Peoples R China [9]307 Hosp PLA, Beijing, Peoples R China [10]Peking Univ, Peoples Hosp, Beijing, Peoples R China
出处：
DOI： 10.1200/JCO.2021.39.15_suppl.e15585
ISSN：
基金：
National Natural Science Foundation of China [61435001]; CAMS Innovation Fund for Medical Sciences [2016-I2M-1-001, 2017-I2M-4-003]

基金编号： 61435001 2016-I2M-1-001 2017-I2M-4-003

语种：
外文
被引次数：
WOS：
中科院(CAS)分区：
出版当年[2020]版：
大类 | 1 区 医学
小类 | 1 区 肿瘤学
最新[2023]版：
大类 | 1 区 医学
小类 | 1 区 肿瘤学
JCR分区：
出版当年[2019]版：
Q1 ONCOLOGY
最新[2023]版：
Q1 ONCOLOGY

影响因子： 最新[2023版] 最新五年平均 出版当年[2019版] 出版当年五年平均 出版前一年[2018版] 出版后一年[2020版]

第一作者：
第一作者机构： [1]Peking Union Med Coll Hosp, Beijing, Peoples R China [2]Chinese PLA Gen Hosp, Dept Med Oncol, Beijing, Peoples R China [3]Beijing Hosp, Beijing, Peoples R China [4]Capital Med Univ, Beijing Chaoyang Hosp, Beijing, Peoples R China [5]Capital Med Univ, Beijing Friendship Hosp, Beijing, Peoples R China [6]Shanxi Med Univ, Affiliated Canc Hosp, Shanxi Canc Hosp, Taiyuan, Peoples R China [7]Hosp Acad Mil Med Sci, Beijing, Peoples R China [8]Capital Med Univ, Xuanwu Hosp, Beijing, Peoples R China [9]307 Hosp PLA, Beijing, Peoples R China [10]Peking Univ, Peoples Hosp, Beijing, Peoples R China
推荐引用方式(GB/T 7714)：
Yang Kaili,Han Lu,Zhao Yun-Bo,et al.Regorafenib plus PD-1 inhibitors in Chinese patients with microsatellite stable/mismatch repair proficient metastatic colorectal cancer: A real-world study[J].JOURNAL OF CLINICAL ONCOLOGY.2021,39(15):doi:10.1200/JCO.2021.39.15_suppl.e15585.
APA：
Yang, Kaili,Han, Lu,Zhao, Yun-Bo,Ge, Yang,Li, Qin...&Zhao, Lin.(2021).Regorafenib plus PD-1 inhibitors in Chinese patients with microsatellite stable/mismatch repair proficient metastatic colorectal cancer: A real-world study.JOURNAL OF CLINICAL ONCOLOGY,39,(15)
MLA：
Yang, Kaili,et al."Regorafenib plus PD-1 inhibitors in Chinese patients with microsatellite stable/mismatch repair proficient metastatic colorectal cancer: A real-world study".JOURNAL OF CLINICAL ONCOLOGY 39..15(2021)

资源点击量：16461 今日访问量：0 总访问量：871 更新日期：2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持：重庆聚合科技有限公司 地址：北京市西城区长椿街45号宣武医院